tiprankstipranks
Trending News
More News >
CAMP4 Therapeutics Corporation (CAMP)
NASDAQ:CAMP
US Market
Advertisement

CAMP4 Therapeutics Corporation (CAMP) Ratios

Compare
44 Followers

CAMP4 Therapeutics Corporation Ratios

CAMP's free cash flow for Q4 2025 was $1.00. For the 2025 fiscal year, CAMP's free cash flow was decreased by $ and operating cash flow was $-15.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
8.02 1.64 2.01 2.00 1.96
Quick Ratio
8.02 1.42 1.80 1.78 1.66
Cash Ratio
7.66 0.39 0.88 0.88 0.88
Solvency Ratio
-4.47 -0.03 -0.03 <0.01 -0.13
Operating Cash Flow Ratio
-7.56 -0.22 -0.05 0.27 0.10
Short-Term Operating Cash Flow Coverage
-15.65 -32.53 -1.63 6.62 0.35
Net Current Asset Value
$ 40.47M$ -191.02M$ -134.80M$ -124.43M$ -120.02M
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.63 0.53 0.47 0.47
Debt-to-Equity Ratio
0.15 16.81 2.73 2.14 1.70
Debt-to-Capital Ratio
0.13 0.94 0.73 0.68 0.63
Long-Term Debt-to-Capital Ratio
0.00 0.94 0.73 0.68 0.59
Financial Leverage Ratio
1.22 26.57 5.19 4.56 3.59
Debt Service Coverage Ratio
-16.42 -0.13 0.36 0.89 -0.10
Interest Coverage Ratio
0.00 -3.43 -1.00 -0.25 -0.83
Debt to Market Cap
0.11 0.07 0.04 0.02 0.03
Interest Debt Per Share
0.40 6.83 6.27 6.42 7.61
Net Debt to EBITDA
0.80 719.23 16.88 6.01 8.35
Profitability Margins
Gross Profit Margin
72.32%36.96%41.20%39.67%39.14%
EBIT Margin
-3530.60%0.00%0.00%0.00%0.00%
EBITDA Margin
-3419.27%0.09%2.53%5.88%4.16%
Operating Profit Margin
-3530.60%-7.28%-5.18%-1.25%-4.58%
Pretax Profit Margin
-3428.61%-10.63%-10.16%-6.67%-15.93%
Net Profit Margin
-3428.61%-11.02%-10.53%-6.86%-21.52%
Continuous Operations Profit Margin
-3428.61%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%103.67%103.62%102.72%135.07%
EBT Per EBIT
97.11%145.88%196.31%532.33%347.76%
Return on Assets (ROA)
-82.47%-8.55%-7.95%-4.88%-15.89%
Return on Equity (ROE)
708.57%-227.09%-41.31%-22.25%-57.12%
Return on Capital Employed (ROCE)
-94.64%-7.85%-5.09%-1.18%-4.48%
Return on Invested Capital (ROIC)
-84.36%-8.12%-5.22%-1.20%-5.56%
Return on Tangible Assets
-82.47%-12.53%-11.75%-7.01%-22.93%
Earnings Yield
-184.32%-0.92%-0.54%-0.23%-1.06%
Efficiency Ratios
Receivables Turnover
14.25 3.56 4.81 4.87 5.07
Payables Turnover
6.84 3.53 5.47 5.21 7.83
Inventory Turnover
0.00 7.78 9.52 7.87 6.06
Fixed Asset Turnover
0.16 6.54 5.92 5.57 4.79
Asset Turnover
0.02 0.78 0.76 0.71 0.74
Working Capital Turnover Ratio
0.03 3.70 2.99 2.76 1.68
Cash Conversion Cycle
-27.73 46.08 47.51 51.17 85.70
Days of Sales Outstanding
25.62 102.65 75.93 74.90 72.05
Days of Inventory Outstanding
0.00 46.92 38.33 46.39 60.25
Days of Payables Outstanding
53.35 103.48 66.76 70.12 46.61
Operating Cycle
25.62 149.57 114.26 121.29 132.30
Cash Flow Ratios
Operating Cash Flow Per Share
-2.50 -0.64 -0.12 0.84 0.34
Free Cash Flow Per Share
-2.53 -0.94 -0.50 0.50 -0.32
CapEx Per Share
0.04 0.31 0.38 0.33 0.66
Free Cash Flow to Operating Cash Flow
1.01 1.48 4.15 0.60 -0.92
Dividend Paid and CapEx Coverage Ratio
-69.09 -2.07 -0.32 2.52 0.52
Capital Expenditure Coverage Ratio
-69.09 -2.07 -0.32 2.52 0.52
Operating Cash Flow Coverage Ratio
-6.19 -0.10 -0.02 0.14 0.05
Operating Cash Flow to Sales Ratio
-32.25 -0.08 -0.01 0.09 0.03
Free Cash Flow Yield
-170.19%-0.96%-0.31%0.19%-0.14%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.54 -109.12 -183.79 -438.48 -94.03
Price-to-Sales (P/S) Ratio
19.29 12.02 19.35 30.06 20.23
Price-to-Book (P/B) Ratio
0.55 247.81 75.92 97.57 53.70
Price-to-Free Cash Flow (P/FCF) Ratio
-0.59 -104.18 -326.82 538.45 -695.60
Price-to-Operating Cash Flow Ratio
-0.58 -154.60 -1.36K 324.54 641.61
Price-to-Earnings Growth (PEG) Ratio
-0.04 -48.01 -4.38 5.97 0.17
Price-to-Fair Value
0.55 247.81 75.92 97.57 53.70
Enterprise Value Multiple
0.24 13.56K 781.07 517.61 495.09
Enterprise Value
-12.42M 3.74B 5.85B 9.39B 7.53B
EV to EBITDA
0.24 13.56K 781.07 517.61 495.09
EV to Sales
-8.23 12.69 19.78 30.42 20.58
EV to Free Cash Flow
0.25 -110.01 -334.04 544.77 -707.53
EV to Operating Cash Flow
0.26 -163.26 -1.39K 328.35 652.62
Tangible Book Value Per Share
2.64 -2.95 -1.45 -1.08 -0.43
Shareholders’ Equity Per Share
2.64 0.40 2.14 2.79 4.12
Tax and Other Ratios
Effective Tax Rate
0.01 -0.04 -0.04 -0.03 -0.35
Revenue Per Share
0.08 8.17 8.39 9.04 10.94
Net Income Per Share
-2.65 -0.90 -0.88 -0.62 -2.35
Tax Burden
1.00 1.04 1.04 1.03 1.35
Interest Burden
0.97----
Research & Development to Revenue
26.10 0.08 0.10 0.08 0.08
SG&A to Revenue
10.32 0.18 0.18 0.16 0.16
Stock-Based Compensation to Revenue
2.67 0.03 0.04 0.04 0.03
Income Quality
0.94 0.71 0.14 -1.35 -0.15
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis